Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Confusional state, Dyspnoea, Fatigue, Hepatic enzyme
Clinical narrative: sporadic lung partial collapse when on side; high fever; Difficulty breathing; weight on chest; asthma attacks; liver enzymes increase; bilirubin high; rashes to blisters; rashes to blisters; itching; fatigue; confusion; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 15 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 09Jul2021 13:30 (Lot number: EW0186) at the age of 15 years as dose 1 , single for covid-19 immunisation. Relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing). There were no concomitant medications. There was No other vaccine in four weeks and medications in two weeks. The following information was reported: PNEUMOTHORAX (medically significant) with onset 09Jul2021 15:30, outcome "recovering", described as "sporadic lung partial collapse when on side"; PYREXIA (non-serious) with onset 09Jul2021 15:30, outcome "recovering", described as "high fever"; DYSPNOEA (non-serious) with onset 09Jul2021 15:30, outcome "recovering", described as "Difficulty breathing"; CHEST DISCOMFORT (non-serious) with onset 09Jul2021 15:30, outcome "recovering", described as "weight on chest"; ASTHMA (non-serious) with onset 09Jul2021 15:30, outcome "recovering", described as "asthma attacks"; HEPATIC ENZYME INCREASED (non-serious) with onset 09Jul2021 15:30, outcome "recovering", described as "liver enzymes increase"; BLOOD BILIRUBIN INCREASED (non-serious) with onset 09Jul2021 15:30, outcome "recovering", described as "bilirubin high"; RASH (non-serious), BLISTER (non-serious) all with onset 09Jul2021 15:30, outcome "recovering" and all described as "rashes to blisters"; PRURITUS (non-serious) with onset 09Jul2021 15:30, outcome "recovering", described as "itching"; FATIGUE (non-serious) with onset 09Jul2021 15:30, outcome "recovering", described as "fatigue"; CONFUSIONAL STATE (non-serious) with onset 09Jul2021 15:30, outcome "recovering", described as "confusion". Within 2 hours, high fever, Difficulty breathing, weight on chest, sporadic lung partial collapse when on side, asthma attacks for next 10 days(no previous history), liver enzymes increase and bilirubin high, rashes to blisters, itching, fatigue, confusion. The events "sporadic lung partial collapse when on side", "high fever", "difficulty breathing", "weight on chest", "asthma attacks", "liver enzymes increase", "bilirubin high", "rashes to blisters", "rashes to blisters", "itching", "fatigue" and "confusion" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: blood bilirubin: (09Jul2021) high; chest x-ray: (09Jul2021) clear; hepatic enzyme: (09Jul2021) increase; pyrexia: (09Jul2021) high fever; sars-cov-2 test: (10Jul2021) negative, notes: Nasal swab. Therapeutic measures were taken as a result of pneumothorax, pyrexia, dyspnoea, chest discomfort, asthma, hepatic enzyme increased, blood bilirubin increased, rash, blister, pruritus, fatigue, confusional state. No other vaccine in four weeks. No other medications in two weeks. AE resulted in at Doctor or other healthcare professional office/clinic visit, Emergency room/department. AE treatment received with 4 Zyrtec daily, inhaler steroid, singular, Pepcid. Patient did not have covid prior vaccination and tested covid post vaccination.  No follow-up attempts are possible. No further information is expected.